Camu-camu ⬇️ #hepatic #steatosis & #liver injury markers in #overweight, #hypertriglyceridemic adults: A randomized crossover trial @_atanas_ @_INPST @ScienceCommuni2 @DHPSP @Grimhood @DrRPalmquist @erlesen https://t.co/z7SoNIPXwS
Camu-camu decreases hepatic steatosis and liver injury markers in overweight, hypertriglyceridemic individuals: A randomized crossover trial.
Mentions
Extended reach
Total likes
Video views
Mentions per month
Aug 2024 – Sep 2024Where it's discussed
-
News51 articles
-
X / Twitter16 posts
-
Blogs4 articles
-
YouTube2 videos
AI synopsis
What people are saying
Discussions show enthusiasm with phrases like 'promising benefits' and mention of natural antioxidants, signaling strong interest. The tone varies from supportive acknowledgment to curiosity about implications, with some posts referencing the specific study design to indicate engagement. Overall, the conversations suggest a recognition of the research's possible influence on health practices without extraordinary claims of revolutionizing treatment.
Most discussions recognize the positive findings of the study, noting camu-camu's potential benefits for liver health.
Posts show a high level of curiosity, highlighting the natural fruit's antioxidants and its promising health implications.
Several discussions include detailed mentions of the study's methodology and potential uses, indicating moderate to deep engagement.
Some posts suggest the research could influence dietary approaches or treatments for liver issues, reflecting a recognition of its potential impact.
Abstract in brief
- Non-alcoholic fatty liver disease (NAFLD) affects 25% of adults, and there are currently no effective drug treatments for it.
- Previous studies indicated that a polyphenol-rich extract from camu-camu berries might prevent fat accumulation in the liver in mice.
- A 12-week trial with 30 overweight adults found that camu-camu significantly reduced liver fat and positively altered gut microbiota compared to a placebo, suggesting its potential as a dietary intervention for reducing NAFLD risk.
Top posts
Most liked on X and BlueskyCamu-camu decreases hepatic steatosis and liver injury markers in overweight, hypertriglyceridemic individuals https://t.co/yx6Dd8FzHy
Prometteur pour les NASH Camu-camu decreases hepatic steatosis and liver injury markers in overweight, hypertriglyceridemic individuals: A randomized crossover trial: Cell Reports Medicine https://t.co/Jvyl60WU2E
RT @HealthyFellow: Camu-camu ⬇️ #hepatic #steatosis & #liver injury markers in #overweight, #hypertriglyceridemic adults: A randomized cros…
Online now: Camu-camu decreases hepatic steatosis and liver injury markers in overweight, hypertriglyceridemic individuals: A randomized crossover trial https://t.co/HCMY5ruugR
RT @HealthyFellow: Camu-camu ⬇️ #hepatic #steatosis & #liver injury markers in #overweight, #hypertriglyceridemic adults: A randomized cros…
All mentions
Camu-Camu Reduces Liver Fat and Improves Function in Overweight Adults
Recent research suggests that camu-camu, a vibrant Amazonian fruit packed with antioxidants, may offer significant benefits for liver health. A 12-week trial found it reduces liver fat and improves markers in overweight…
Camu-Camu's Role in Improving Liver Health and Reducing Fat Accumulation
Recent research suggests that camu-camu, a vibrant Amazonian fruit packed with antioxidants, may offer significant benefits for liver health. A 12-week trial showed it reduces liver fat and improves liver function in…
Camu-camu decreases hepatic steatosis and liver injury markers in overweight, hypertriglyceridemic individuals: A randomized crossover trial https://t.co/IdFEdgxQFK Not Medical Advice || DavidPS
The Liver-Healthy Benefits of Camu-Camu Ep. 1206 SEP 2024 https://t.co/ltJvag8rPV via @YouTube The Liver-Healthy Benefits of Camu-Camu Ep. 1206 SEP 2024 Recent research suggests that camu-camu, a vibrant Amazonian fruit packed with antioxidants, may offer significant benefits
The Liver-Healthy Benefits of Camu-Camu Ep. 1206 SEP 2024 #trailer https://t.co/cIRbnbMq23 via @YouTube Recent research suggests that camu-camu, a vibrant Amazonian fruit packed with antioxidants, may offer significant benefits for liver health. Studies have shown that camu-camu
RT @HealthyFellow: Camu-camu ⬇️ #hepatic #steatosis & #liver injury markers in #overweight, #hypertriglyceridemic adults: A randomized cros…
RT @HealthyFellow: Camu-camu ⬇️ #hepatic #steatosis & #liver injury markers in #overweight, #hypertriglyceridemic adults: A randomized cros…
Online now: Camu-camu decreases hepatic steatosis and liver injury markers in overweight, hypertriglyceridemic individuals: A randomized crossover trial https://t.co/HCMY5ruugR
RT @HealthyFellow: Camu-camu ⬇️ #hepatic #steatosis & #liver injury markers in #overweight, #hypertriglyceridemic adults: A randomized cros…
RT @HealthyFellow: Camu-camu ⬇️ #hepatic #steatosis & #liver injury markers in #overweight, #hypertriglyceridemic adults: A randomized cros…
RT @HealthyFellow: Camu-camu ⬇️ #hepatic #steatosis & #liver injury markers in #overweight, #hypertriglyceridemic adults: A randomized cros…
RT @HealthyFellow: Camu-camu ⬇️ #hepatic #steatosis & #liver injury markers in #overweight, #hypertriglyceridemic adults: A randomized cros…
RT @HealthyFellow: Camu-camu ⬇️ #hepatic #steatosis & #liver injury markers in #overweight, #hypertriglyceridemic adults: A randomized cros…
RT @HealthyFellow: Camu-camu ⬇️ #hepatic #steatosis & #liver injury markers in #overweight, #hypertriglyceridemic adults: A randomized cros…
Camu-camu ⬇️ #hepatic #steatosis & #liver injury markers in #overweight, #hypertriglyceridemic adults: A randomized crossover trial @_atanas_ @_INPST @ScienceCommuni2 @DHPSP @Grimhood @DrRPalmquist @erlesen https://t.co/z7SoNIPXwS
Camu-Camu, a small tart red berry found to reduce Non-alcoholic fatty liver disease (NAFLD). https://t.co/JkJdaE2Jye
Prometteur pour les NASH Camu-camu decreases hepatic steatosis and liver injury markers in overweight, hypertriglyceridemic individuals: A randomized crossover trial: Cell Reports Medicine https://t.co/Jvyl60WU2E
Camu-camu decreases hepatic steatosis and liver injury markers in overweight, hypertriglyceridemic individuals https://t.co/yx6Dd8FzHy